Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cell Surface Expression of the Bovine Leukemia Virus-Binding Receptor on B and T Lymphocytes Is Induced by Receptor Engagement

Madakasira Lavanya, Sandrina Kinet, Amélie Montel-Hagen, Cédric Mongellaz, Jean-Luc Battini, Marc Sitbon and Naomi Taylor
J Immunol July 15, 2008, 181 (2) 891-898; DOI: https://doi.org/10.4049/jimmunol.181.2.891
Madakasira Lavanya
Institut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5535/IFR 24, Université Montpellier I and II, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandrina Kinet
Institut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5535/IFR 24, Université Montpellier I and II, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amélie Montel-Hagen
Institut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5535/IFR 24, Université Montpellier I and II, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cédric Mongellaz
Institut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5535/IFR 24, Université Montpellier I and II, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Luc Battini
Institut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5535/IFR 24, Université Montpellier I and II, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Sitbon
Institut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5535/IFR 24, Université Montpellier I and II, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naomi Taylor
Institut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5535/IFR 24, Université Montpellier I and II, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Schematic representation of tagged BLV-truncated RBD. Schematic representation of the BLV envelope glycoprotein. The signal peptide (SP) and the extracellular (SU) and transmembrane (TM) components of BLV Env are represented as a modular organization based on that of HTLV Env (17 ). The amino-terminal 182 residues of BLV Env, encompassing the cleaved off signal peptide (SP), the putative RBD in SU, with or without the PRR (wavy line), were fused to either a carboxyl-terminal Fc domain of a rabbit IgG (BRBDrFc) or eGFP (BRBDeGFP), respectively.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    BLV-truncated RBD bind to the BLV receptor, a molecule distinct from Glut1. A, The specificity of BRBD receptor binding was validated by an envelope interference assay wherein 293T cells were transiently transfected with a control plasmid, the BRBDrFc expression plasmid (top panels) or the entire BLV Env (bottom panels) and assessed 48 h later for binding to BRBDeGFP and HRBDeGFP. Representative histograms showing staining of control-transfected (solid black line), BRBDrFc-transfected, and BLV Env-transfected (dashed line) 293T cells are presented. Nonspecific background staining is depicted as a filled histogram. The MFI of BRBDeGFP staining following BRBDrFc and BLV Env transfection changed from 30 to 15 and 95 to 27, respectively, while the MFI of HRBDeGFP staining changed from 14 to 17 and 13 to 12, respectively. B, 293T cells were transiently transfected with a control plasmid or a Glut1 expression vector. Thirty-six hours after transfection, cells were stained with either a rFc-tagged HTLV-2 RBD (HRBDrFc) that binds Glut1 (19 28 31 60 ) (upper panels) or the rFc-tagged BLV RBD (BRBDrFc, lower panels), followed by incubation with a secondary FITC-conjugated sheep anti-rabbit Ab. Filled histograms depict control binding. C, Binding of HRBDrFc and BRBDrFc was monitored on human red cells as described above. Staining profiles are presented in comparison to background binding (filled histogram). Data are representative of results obtained in three independent experiments.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    The BLV Env- binding receptor is expressed on diverse cell lines of different species and is down-regulated upon BLV infection. A, BRBDrFc was used to assess the cell surface expression of the BLV- binding receptor on transformed cell lines derived from the following species; human (293T, TE671, HeLa, JY, and Jurkat), simian (COS-7), porcine (PK15), dog (D17), hamster (A23), mink (CCL64), and mouse (Dunni and NIH3T3). Expression was also monitored on the Sf9 insect cell line. Cells were incubated with the BRBDrFc for 30 min at 37°C, followed by incubation with a FITC-conjugated anti-rabbit Fc Ab at 4°C. Binding was monitored by flow cytometry. Filled histograms depict background binding in the presence of the secondary FITC-conjugated anti-rabbit Ab alone while specific binding is shown as a solid line. Data are representative of results obtained in at least two independent experiments. B, BRBDrFc binding was assessed on bovine (TEK, KNS-R, and BL3) and ovine (PO) cell lines (top panels) as well as on the BLV-infected PO cell line and the fetal lamb kidney cell line (FLK-BLV) (bottom panels).

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    The BLV-binding receptor is expressed on differentiating B cells and is induced on mature B cell following receptor activation. A, Expression of the BLV-binding receptor on differentiating B cells was monitored in mouse BM. Pro-/pre-B cells, immature B cells, and mature B cells were distinguished on the basis of IgM and B220 expression as shown and BRBDrFc binding in the three subsets is shown. B, BRBDrFc binding was assessed in freshly isolated (−) B220+ spleen and LN cells isolated from C57BL/6 mice as well as 48 h after LPS (20 μg/ml) stimulation (+). Human CD19+ lymphocytes were purified by positive selection and BRBDrFc binding was assessed before (−) and after (+) 3 days of BCR stimulation with an anti-IgM mAb (20 μg/ml).

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    The BLV-binding receptor is an early marker of TCR stimulation and its expression requires protein synthesis. A, Human umbilical cord CD4+ T lymphocytes were purified by negative selection. Expression of CD69, CD25, and the BLV Env-binding receptor was assessed on freshly isolated cells (0 h) and after 2, 4, 6, 8, 16, and 24 h of TCR stimulation with immobilized anti-CD3 and anti-CD28 mAbs (solid line histograms). Expression of these markers at each time point was also evaluated in the presence of the protein synthesis inhibitor CHX (5 μg/ml; dashed histograms). Background fluorescence obtained with the secondary FITC-conjugated Ab alone is shown in each histogram (filled histograms). B, BLV Env-binding receptor expression was also assessed at extended time points after 3, 6, and 11 days of TCR stimulation as well as on T cells undergoing homeostatic proliferation induced by rIL-7 stimulation (10 ng/ml). Data are representative of results obtained in at least two independent experiments.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    IL-7-responsive human thymocytes express high BLV Env-binding receptor levels. Expression of the BLV Env-binding receptor was assessed on human thymocytes immediately upon isolation or following a 5-day culture in the presence or absence of rIL-7 (10 g/ml) for 5 days. Following IL-7 stimulation, BLV Env-binding receptor expression was assessed on the non-blast and blast populations as determined by forward and side scatter profiles. The gates used for analyses of thymocyte subsets are shown. The distribution of DN, CD4+CD8+ DP, CD4+ SP (SP4) and CD8+ SP (SP8) thymocyte populations within the indicated gates is presented. The relative expression of the BLV Env-binding receptor within each of these subsets was determined by incubation of thymocytes with BRBDrFc and secondary anti-rabbit IgG before staining with anti-CD4 and anti-CD8 mAbs. Histograms of BRBDrFc staining in the DN, DP, SP4, and SP8 populations are shown. Background staining obtained with the secondary FITC-conjugated Ab alone is depicted as filled histograms.

PreviousNext
Back to top

In this issue

The Journal of Immunology: 181 (2)
The Journal of Immunology
Vol. 181, Issue 2
15 Jul 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cell Surface Expression of the Bovine Leukemia Virus-Binding Receptor on B and T Lymphocytes Is Induced by Receptor Engagement
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cell Surface Expression of the Bovine Leukemia Virus-Binding Receptor on B and T Lymphocytes Is Induced by Receptor Engagement
Madakasira Lavanya, Sandrina Kinet, Amélie Montel-Hagen, Cédric Mongellaz, Jean-Luc Battini, Marc Sitbon, Naomi Taylor
The Journal of Immunology July 15, 2008, 181 (2) 891-898; DOI: 10.4049/jimmunol.181.2.891

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cell Surface Expression of the Bovine Leukemia Virus-Binding Receptor on B and T Lymphocytes Is Induced by Receptor Engagement
Madakasira Lavanya, Sandrina Kinet, Amélie Montel-Hagen, Cédric Mongellaz, Jean-Luc Battini, Marc Sitbon, Naomi Taylor
The Journal of Immunology July 15, 2008, 181 (2) 891-898; DOI: 10.4049/jimmunol.181.2.891
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Disclosures
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction
  • Regulatory Roles of IL-2 and IL-4 in H4/Inducible Costimulator Expression on Activated CD4+ T Cells During Th Cell Development
  • Induction of CD4+ T Cell Apoptosis as a Consequence of Impaired Cytoskeletal Rearrangement in UVB-Irradiated Dendritic Cells
Show more CELLULAR IMMUNOLOGY AND IMMUNE REGULATION

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606